Skip to main content
SpringerLink
Log in

1p/19q intakte anaplastische Gliome

Strahlentherapie plus Temozolomid als neuer Behandlungsstandard?

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Stupp R et al. N Engl J Med 2005; 352:987–96

    Article  CAS  Google Scholar 

  2. Hegi ME et al. N Engl J Med 2005; 352:997–1003

    Article  CAS  Google Scholar 

  3. van den Bent MJ et al. J Clin Oncol 2006; 24:2715–22

    Article  Google Scholar 

  4. Cairncross JG et al. J Clin Oncol 2006; 24:2707–14

    Article  CAS  Google Scholar 

  5. van den Bent MJ et al. J Clin Oncol 2013; 31:344–50

    Article  Google Scholar 

  6. Cairncross G et al. J Clin Oncol 2013; 31:337–43

    Article  CAS  Google Scholar 

  7. Buckner JC et al. N Engl J Med 2016; 374:1344–55

    Article  CAS  Google Scholar 

  8. Wick W et al. Neuro Oncol 2016; 8:1529–37

    Google Scholar 

  9. Baumert BG et al. Lancet Oncol 2016; 17:1521–32

    Article  CAS  Google Scholar 

Literatur

  • van den Bent MJ, Baumert B, Erridge SC et al. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet 2017; 390: 1645–53

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Neurologie, Universitätsklinikum Essen, Essen, Deutschland

    Martin Glas (Leiter Abteilung Klinische Neuroonkologie)

Authors
  1. Martin Glas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Glas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glas, M. Strahlentherapie plus Temozolomid als neuer Behandlungsstandard?. InFo Neurologie 20, 26–27 (2018). https://doi.org/10.1007/s15005-018-2575-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-018-2575-0

Search

Navigation